<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/821"/><api:result><api:object category="publication" id="821" last-affected-when="2024-03-18T02:10:03.987+00:00" last-modified-when="2024-03-18T02:10:03.987+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/821" created-when="2010-05-17T13:46:30.183+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-03-06</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518211" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0264-410X(99)00483-1" last-modified-when="2023-04-23T09:03:25.05+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0264-410x(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0264-410x(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0264-410x(99)00483-1"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vaccine</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0264-410x(99)00483-1</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>16</api:day><api:month>4</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="95834" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034004314" last-modified-when="2020-09-01T22:07:54.967+01:00"><api:citation-count>5</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Therapeutic immunisation may represent a means of influencing viral infections that persist in the host by modulating the nature or level of host immunity. To assess the influence of the form of the antigenic stimulus on immunity to type-2 herpes simplex virus (HSV-2), mice pre-infected with sublethal doses of HSV-2 were immunised with various HSV-2 vaccine formulations prior to challenge infection with heterologous HSV-1. Measurements of interleukin-2 (IL-2), interleukin-4 (IL-4) and interferon-γ (IFN-γ) levels in mouse spleen cell cultures restimulated in vitro with HSV- 2 antigens showed that, depending on the form of HSV-2 antigen preparation used in this therapeutic context, changes in the levels of these cytokines could be effected. Measurement of HSV-specific antibody by serological tests support the contention that immunisation of HSV-2-infected mice can either enhance the existing Th1-like immune response elicited following HSV-2 infection, or modulate this response towards a more Th2-like profile, and this is dependent on the form of the antigenic stimulus. The degree of protection against subsequent lethal, heterologous HSV-1 challenge infection varied according to the nature of the infection and the immunisation history of the animals. © 2000 Elsevier Science Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56628367900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7201835305</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7201971819</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0264-410X(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0264-410X(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0264-410X(99)00483-1"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10699326</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vaccine</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>6</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: Influence of vaccine formulation on immune responses and protection in mice</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="821" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10699326" last-modified-when="2020-04-29T05:33:48.88+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Therapeutic immunisation may represent a means of influencing viral infections that persist in the host by modulating the nature or level of host immunity. To assess the influence of the form of the antigenic stimulus on immunity to type-2 herpes simplex virus (HSV-2), mice pre-infected with sublethal doses of HSV-2 were immunised with various HSV-2 vaccine formulations prior to challenge infection with heterologous HSV-1. Measurements of interleukin-2 (IL-2), interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) levels in mouse spleen cell cultures restimulated in vitro with HSV-2 antigens showed that, depending on the form of HSV-2 antigen preparation used in this therapeutic context, changes in the levels of these cytokines could be effected. Measurement of HSV-specific antibody by serological tests support the contention that immunisation of HSV-2-infected mice can either enhance the existing Th1-like immune response elicited following HSV-2 infection, or modulate this response towards a more Th2-like profile, and this is dependent on the form of the antigenic stimulus. The degree of protection against subsequent lethal, heterologous HSV-1 challenge infection varied according to the nature of the infection and the immunisation history of the animals.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Sheffield Institute for Vaccine Studies and Division of Molecular and Genetic Medicine, "F" Floor, University of Sheffield Medical School, Beech Hill Road, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10699326</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0264-410x(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0264-410x(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0264-410x(99)00483-1"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vaccine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">Immunity, Cellular</api:keyword><api:keyword scheme="mesh">Immunoglobulin G</api:keyword><api:keyword scheme="mesh">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword><api:keyword scheme="mesh">Interleukin-2</api:keyword><api:keyword scheme="mesh">Interleukin-4</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Spleen</api:keyword><api:keyword scheme="mesh">Th1 Cells</api:keyword><api:keyword scheme="mesh">Th2 Cells</api:keyword><api:keyword scheme="mesh">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Netherlands</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0264410X99004831</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>6</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>13</api:day><api:month>4</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="882081" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10699326" last-modified-when="2020-06-09T17:56:56.24+01:00"><api:citation-count>4</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Therapeutic immunisation may represent a means of influencing viral infections that persist in the host by modulating the nature or level of host immunity. To assess the influence of the form of the antigenic stimulus on immunity to type-2 herpes simplex virus (HSV-2), mice pre-infected with sublethal doses of HSV-2 were immunised with various HSV-2 vaccine formulations prior to challenge infection with heterologous HSV-1. Measurements of interleukin-2 (IL-2), interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) levels in mouse spleen cell cultures restimulated in vitro with HSV-2 antigens showed that, depending on the form of HSV-2 antigen preparation used in this therapeutic context, changes in the levels of these cytokines could be effected. Measurement of HSV-specific antibody by serological tests support the contention that immunisation of HSV-2-infected mice can either enhance the existing Th1-like immune response elicited following HSV-2 infection, or modulate this response towards a more Th2-like profile, and this is dependent on the form of the antigenic stimulus. The degree of protection against subsequent lethal, heterologous HSV-1 challenge infection varied according to the nature of the infection and the immunisation history of the animals.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Sheffield Institute for Vaccine Studies and Division of Molecular and Genetic Medicine, "F" Floor, University of Sheffield Medical School, Beech Hill Road, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0264-410x(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0264-410x(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0264-410x(99)00483-1"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1873-2518</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10699326</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vaccine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Spleen</api:keyword><api:keyword scheme="mesh">Th1 Cells</api:keyword><api:keyword scheme="mesh">Th2 Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Immunoglobulin G</api:keyword><api:keyword scheme="mesh">Interleukin-2</api:keyword><api:keyword scheme="mesh">Interleukin-4</api:keyword><api:keyword scheme="mesh">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Immunity, Cellular</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>4</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="2507126" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1026281637" last-modified-when="2024-03-18T02:10:03.99+00:00"><api:citation-count>6</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01246601362.08</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0657140264.85</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01164605622.09</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0264-410x(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0264-410x(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0264-410x(99)00483-1"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10699326</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>0.5</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Vaccine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3204 Immunology</api:keyword><api:keyword scheme="rcdc">Vaccine Related</api:keyword><api:keyword scheme="rcdc">Infectious Diseases</api:keyword><api:keyword scheme="rcdc">Biotechnology</api:keyword><api:keyword scheme="rcdc">Immunization</api:keyword><api:keyword scheme="rcdc">Biodefense</api:keyword><api:keyword scheme="rcdc">Sexually Transmitted Infections</api:keyword><api:keyword scheme="rcdc">Prevention</api:keyword><api:keyword scheme="hrcs-rac">3.4 Vaccines</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">3 Prevention of disease and conditions, and promotion of well-being</api:keyword><api:keyword scheme="hrcs-hc">Inflammatory and immune system</api:keyword><api:keyword scheme="hrcs-hc">Infection</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Antibodies, Viral</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Herpes Genitalis</api:keyword><api:keyword scheme="mesh">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh">Immunity, Cellular</api:keyword><api:keyword scheme="mesh">Immunoglobulin G</api:keyword><api:keyword scheme="mesh">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh">Interferon-gamma</api:keyword><api:keyword scheme="mesh">Interleukin-2</api:keyword><api:keyword scheme="mesh">Interleukin-4</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh">Neutralization Tests</api:keyword><api:keyword scheme="mesh">Spleen</api:keyword><api:keyword scheme="mesh">Th1 Cells</api:keyword><api:keyword scheme="mesh">Th2 Cells</api:keyword><api:keyword scheme="mesh">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh">Viral Vaccines</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.09</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="241368" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000085898500008" last-modified-when="2024-03-14T05:56:22.077+00:00"><api:citation-count>5</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000085898500008&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0264-410X(99)00483-1</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0264-410X(99)00483-1"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0264-410X(99)00483-1"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">294EN</api:identifier><api:identifier scheme="pubmed">10699326</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>VACCINE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>genital herpes</api:keyword><api:keyword>ISCOMs</api:keyword><api:keyword>interferon-gamma</api:keyword><api:keyword>interleukin-4</api:keyword><api:keyword>therapeutic immunisation</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record><api:record format="native" id="24337" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000085898500008" last-modified-when="2014-07-25T11:05:50.533+01:00"><api:citation-count>5</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mohamedi</api:last-name><api:initials>SA</api:initials><api:first-names>SA</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="2047" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2047"/></api:links><api:last-name>Heath</api:last-name><api:initials>AW</api:initials><api:first-names>AW</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jennings</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-410X</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>17</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>VACCINE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>genital herpes</api:keyword><api:keyword>ISCOMs</api:keyword><api:keyword>interferon-gamma</api:keyword><api:keyword>interleukin-4</api:keyword><api:keyword>therapeutic immunisation</api:keyword><api:keyword>SIMPLEX VIRUS TYPE-1</api:keyword><api:keyword>HUMAN-IMMUNODEFICIENCY-VIRUS</api:keyword><api:keyword>RESPIRATORY SYNCYTIAL VIRUS</api:keyword><api:keyword>GLYCOPROTEIN-D</api:keyword><api:keyword>GENITAL HERPES</api:keyword><api:keyword>EXPRESSION PATTERNS</api:keyword><api:keyword>CELLULAR-IMMUNITY</api:keyword><api:keyword>DELIVERY SYSTEMS</api:keyword><api:keyword>INTERFERON-GAMMA</api:keyword><api:keyword>T-LYMPHOCYTES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1778</api:begin-page><api:end-page>1792</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>6</api:day><api:month>3</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>18</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Immunity, Cellular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Immunoglobulin G</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interferon-gamma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-4</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Spleen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Th1 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Th2 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Viral Vaccines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Spleen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Th1 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Th2 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Immunoglobulin G</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-4</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Viral Vaccines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Immunity, Cellular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interferon-gamma</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3207 Medical Microbiology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3204 Immunology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Vaccine Related</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Infectious Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biotechnology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Immunization</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biodefense</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Sexually Transmitted Infections</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Prevention</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">3.4 Vaccines</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">3 Prevention of disease and conditions, and promotion of well-being</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Inflammatory and immune system</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Infection</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adjuvants, Immunologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibodies, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpes Genitalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpesvirus 1, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Herpesvirus 2, Human</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Immunity, Cellular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Immunoglobulin G</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Injections, Intraperitoneal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interferon-gamma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-4</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mice, Inbred BALB C</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neutralization Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Spleen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Th1 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Th2 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Vaccines, Attenuated</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Viral Vaccines</api:keyword><api:keyword origin="record-data" source="wos-lite">genital herpes</api:keyword><api:keyword origin="record-data" source="wos-lite">ISCOMs</api:keyword><api:keyword origin="record-data" source="wos-lite">interferon-gamma</api:keyword><api:keyword origin="record-data" source="wos-lite">interleukin-4</api:keyword><api:keyword origin="record-data" source="wos-lite">therapeutic immunisation</api:keyword><api:keyword origin="record-data" source="wos">genital herpes</api:keyword><api:keyword origin="record-data" source="wos">ISCOMs</api:keyword><api:keyword origin="record-data" source="wos">interferon-gamma</api:keyword><api:keyword origin="record-data" source="wos">interleukin-4</api:keyword><api:keyword origin="record-data" source="wos">therapeutic immunisation</api:keyword><api:keyword origin="record-data" source="wos">SIMPLEX VIRUS TYPE-1</api:keyword><api:keyword origin="record-data" source="wos">HUMAN-IMMUNODEFICIENCY-VIRUS</api:keyword><api:keyword origin="record-data" source="wos">RESPIRATORY SYNCYTIAL VIRUS</api:keyword><api:keyword origin="record-data" source="wos">GLYCOPROTEIN-D</api:keyword><api:keyword origin="record-data" source="wos">GENITAL HERPES</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION PATTERNS</api:keyword><api:keyword origin="record-data" source="wos">CELLULAR-IMMUNITY</api:keyword><api:keyword origin="record-data" source="wos">DELIVERY SYSTEMS</api:keyword><api:keyword origin="record-data" source="wos">INTERFERON-GAMMA</api:keyword><api:keyword origin="record-data" source="wos">T-LYMPHOCYTES</api:keyword><api:keyword scheme="for" origin="issn-inferred">06 Biological Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">07 Agricultural and Veterinary Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">11 Medical and Health Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Virology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">32 Biomedical and clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">42 Health sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0264-410X" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/976912" title="Vaccine"><api:records><api:record source-name="summary"><api:title>Vaccine</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/821/relationships"/></api:object></api:result></api:response>